Please use this identifier to cite or link to this item:
|Title:||The place of diuretics in the treatment of hypertension in 1993: can we do better?||Austin Authors:||Johnston, Colin I||Affiliation:||Department of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia||Issue Date:||1-Nov-1993||Publication information:||Clinical and Experimental Hypertension (new York, N.y. : 1993); 15(6): 1239-55||Abstract:||Diuretics are the only class of antihypertensive drugs that have been conclusively shown to reduce morbidity and mortality in long term outcome trials. However even in these trials there were difficulties with withdrawals, cross contamination, high usage of 2 or more drugs and adverse effects. Low doses of thiazide diuretics should be recommended because they have equal blood pressure lowering effects with less biochemical changes and adverse reactions. In 3 of the 4 outcome trials in the elderly in which there were significant reductions in cardiovascular morbidity and mortality a potassium sparing agent was used in conjunction with the thiazide diuretic, raising the possibility of additional cardioprotection.||Gov't Doc #:||8268888||URI:||http://ahro.austin.org.au/austinjspui/handle/1/13303||URL:||https://pubmed.ncbi.nlm.nih.gov/8268888||Type:||Journal Article||Subjects:||Aged
Randomized Controlled Trials as Topic
Sodium Chloride Symporter Inhibitors.therapeutic use
|Appears in Collections:||Journal articles|
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.